The neuregulin 1 promoter polymorphism rs6994992 is not associated with chronic schizophrenia or neurocognition

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 147, Issue 7, 2008, Pages 1298-1300

  Crowley, James J ^a   Keefe, Richard S E ^b   Perkins, Diana O ^a   Stroup, T Scott ^a   Lieberman, Jeffrey A ^c   Sullivan, Patrick F ^a,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Och Spine at New York Presbyterian Hospitals   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Association study; Neurocognition; NRG1; rs6994992; Schizophrenia

Indexed keywords

NEU DIFFERENTIATION FACTOR;

ADULT; AFFECT; AGE DISTRIBUTION; AGED; ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; INTELLIGENCE QUOTIENT; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; COGNITION DISORDERS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTELLIGENCE; MALE; NEUREGULIN-1; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); SCHIZOPHRENIA;

EID: 55349094352     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.30727     Document Type: Article

References (12)

1. Gauderman WJ. 2002. Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155(5):478-484.
2. Griffin S, Mindt M, Rankin E, Ritchie A, Scott J. 2002. Estimating premorbid intelligence: Comparison of traditional and contemporary methods across the intelligence continuum. Arch Clin Neuropsychol 17:497-507.
3. Hall J, Whalley HC, Job DE, Baig BJ, McIntosh AM, Evans KL, Thomson PA, Porteous DJ, Cunningham-Owens DG, Johnstone EC, et al. 2006. A neuregulin 1 variant associated with abnormal cortical function and psychotic symptoms. Nat Neurosci 9(12):1477-1478.
4. Keefe RS, Mohs RC, Bilder RM, Harvey PD, Green MF, Meltzer HY, Gold JM, Sano M. 2003. Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: Development, methodology, and rationale. Schizophr Bull 29(1):45-55.
5. Keefe RS, Bilder RM, Harvey PD, Davis SM, Palmer BW, Gold JM, Meltzer H, Green MF, Miller DD, Canive J, et al. 2006. Baseline neurocognitive deficits in the CATIE schizophrenia trial. Neuropsychopharmacology 31:2033-2046.
6. Law AJ, Lipska BK, Weickert CS, Hyde TM, Straub RE, Hashimoto R, Harrison PJ, Kleinman JE, Weinberger DR. 2006. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 50 SNPs associated with the disease. Proc Natl Acad Sci USA 103(17):6747-6752.
7. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15(12):1995-2002.
8. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO, Keefe RS, Davis SM, Davis CE, Lebowitz BD, et al. 2005. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353:1209-1223.
9. Livak KJ. 1999. Allelic discrimination using fluorogenic probes and the 5′ nuclease assay. Genet Anal 14(5-6):143-149.
10. Stefansson H, Sigurdsson E, Steinthorsdottir V, Bjornsdottir S, Sigmundsson T, Ghosh S, Brynjolfsson J, Gunnarsdottir S, Ivarsson O, Chou TT, et al. 2002. Neuregulin 1 and susceptibility to schizophrenia. Am J Human Genet 71(4):877-892.
11. Stefansson H, Sarginson J, Kong A, Yates P, Steinthorsdottir V, Gudfinnsson E, Gunnarsdottir S, Walker N, Petursson H, Crombie C, et al. 2003. Association of neuregulin 1 with schizophrenia confirmed in a Scottish population. Am J Human Genet 72:83-87.
12. Stroup TS, McEvoy JP, Swartz MS, Byerly MJ, Glick ID, Canive JM, McGee MF, Simpson GM, Stevens MC, Lieberman JA. 2003. The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project: schizophrenia trial design and protocol development. Schizophr Bull 29(1):15-31.